Brown, Lisle/Cummings, Inc. Boston Scientific Corp Transaction History
Brown, Lisle/Cummings, Inc.
- $376 Billion
- Q2 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 75,568 shares of BSX stock, worth $7.76 Million. This represents 2.16% of its overall portfolio holdings.
Number of Shares
75,568
Previous 74,393
1.58%
Holding current value
$7.76 Million
Previous $7.5 Billion
8.15%
% of portfolio
2.16%
Previous 2.18%
Shares
15 transactions
Others Institutions Holding BSX
# of Institutions
1,903Shares Held
1.27BCall Options Held
9.71MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$14.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.69 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.56 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.47 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...